相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Profiling specific cell populations within the inflammatory tumor microenvironment by oscillating-gradient diffusion-weighted MRI
Emily Hoffmann et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)
Vascular response patterns to targeted therapies in murine breast cancer models with divergent degrees of malignancy
Emily Hoffmann et al.
BREAST CANCER RESEARCH (2023)
T1 mapping as a surrogate marker of chemotherapy response evaluation in patients with osteosarcoma
Esha Baidya Kayal et al.
EUROPEAN JOURNAL OF RADIOLOGY (2022)
Heterogeneity analysis of MRI T2 maps for measurement of early tumor response to radiotherapy
Michal R. Tomaszewski et al.
NMR IN BIOMEDICINE (2021)
Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13-Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease
Mirjam Gerwing et al.
CANCERS (2021)
Failure of Immunotherapy-The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer
Justyna Blach et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Personalized Medicine: Recent Progress in Cancer Therapy
Valentina Gambardella et al.
CANCERS (2020)
Noninvasive MRI native T1 mapping detects response to MYCN-targeted therapies in the Th-MYCN model of neuroblastoma
Konstantinos Zormpas-Petridis et al.
CANCER RESEARCH (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Cardiac Myxomas Show Elevated Native T1, T2 Relaxation Time and ECV on Parametric CMR
Sarah B. Nasser et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Pre-TACE kurtosis of ADCtotal derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma
Li-Fang Wu et al.
EUROPEAN RADIOLOGY (2019)
The beginning of the end for conventional RECIST - novel therapies require novel imaging approaches
Mirjam Gerwing et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Diffusion weighted cardiovascular magnetic resonance imaging for discriminating acute from non-acute deep venous Thrombus
Gang Wu et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
Wenxiao Jia et al.
CANCER BIOLOGY & MEDICINE (2019)
Histogram Analysis Parameters Apparent Diffusion Coefficient for Distinguishing High and Low-Grade Meningiomas: A Multicenter Study
Alexey Surov et al.
TRANSLATIONAL ONCOLOGY (2018)
Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma
Lei Qin et al.
NEURORADIOLOGY (2017)
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
Maria Kissel et al.
ONCOTARGET (2017)
Heterogeneity of Diffusion-Weighted Imaging in Tumours and the Surrounding Stroma for Prediction of Ki-67 Proliferation Status in Breast Cancer
Ming Fan et al.
SCIENTIFIC REPORTS (2017)
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2*and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)
Daniel R. Messroghli et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2017)
Diffusion-Weighted Imaging: Apparent Diffusion Coefficient Histogram Analysis for Detecting Pathologic Complete Response to Chemoradiotherapy in Locally Advanced Rectal Cancer
Moon Hyung Choi et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
Changes of T2 Relaxation Time From Neoadjuvant Chemotherapy in Breast Cancer Lesions
Li Liu et al.
IRANIAN JOURNAL OF RADIOLOGY (2016)
Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging
T. Y. Jeon et al.
BRITISH JOURNAL OF RADIOLOGY (2015)
Optical In Vivo Imaging of the Alarmin S100A9 in Tumor Lesions Allows for Estimation of the Individual Malignant Potential by Evaluation of Tumor-Host Cell Interaction
Anne Becker et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
NucleusJ: an ImageJ plugin for quantifying 3D images of interphase nuclei
Axel Poulet et al.
BIOINFORMATICS (2015)
Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model
Murali K. Ravoori et al.
PLOS ONE (2015)
Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells - a preclinical MR study in mice
Claudia Weidensteiner et al.
BMC CANCER (2014)
Early changes in apparent diffusion coefficient as an indicator of response to sorafenib in hepatocellular carcinoma
Yi-lei Zhao et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2014)
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
KiBem Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Diffusion MRI and Novel Texture Analysis in Osteosarcoma Xenotransplants Predicts Response to Anti-Checkpoint Therapy
Parastou Foroutan et al.
PLOS ONE (2013)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma
Martha Nowosielski et al.
NEURORADIOLOGY (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
Diffusion and perfusion MRI of the lung and mediastinum
Thomas Henzler et al.
EUROPEAN JOURNAL OF RADIOLOGY (2010)
Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib
Marius Horger et al.
BMC CANCER (2009)
Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla
Peter Gibbs et al.
INVESTIGATIVE RADIOLOGY (2009)
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
[Anonymous]
NEOPLASIA (2009)
Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
James H. Finke et al.
CLINICAL CANCER RESEARCH (2008)
Osteosarcoma - Preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging
Markus Uhl et al.
INVESTIGATIVE RADIOLOGY (2006)
Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats
HC Thoeny et al.
RADIOLOGY (2005)
Diffusion-weighted MR Imaging of intracerebral hemorrhage
BK Kang et al.
KOREAN JOURNAL OF RADIOLOGY (2001)
分享论文
